GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genomics BioSci & Tech Co Ltd (ROCO:4195) » Definitions » Total Equity

Genomics BioSci & Tech Co (ROCO:4195) Total Equity : NT$799.3 Mil (As of Jun. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Genomics BioSci & Tech Co Total Equity?

Genomics BioSci & Tech Co's total equity for the quarter that ended in Jun. 2024 was NT$799.3 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.


Genomics BioSci & Tech Co Total Equity Historical Data

The historical data trend for Genomics BioSci & Tech Co's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genomics BioSci & Tech Co Total Equity Chart

Genomics BioSci & Tech Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 691.64 907.70 679.34 789.13 765.51

Genomics BioSci & Tech Co Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 812.35 789.13 856.05 765.51 799.35

Genomics BioSci & Tech Co Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Genomics BioSci & Tech Co's Total Equity for the fiscal year that ended in Dec. 2023 is calculated as

Total Equity=Total Assets(Q: Dec. 2023 )-Total Liabilities(Q: Dec. 2023 )
=1133.844-368.331
=765.5

Genomics BioSci & Tech Co's Total Equity for the quarter that ended in Jun. 2024 is calculated as

Total Equity=Total Assets(Q: Jun. 2024 )-Total Liabilities(Q: Jun. 2024 )
=1278.703-479.357
=799.3

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Genomics BioSci & Tech Co Total Equity Related Terms

Thank you for viewing the detailed overview of Genomics BioSci & Tech Co's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Genomics BioSci & Tech Co Business Description

Traded in Other Exchanges
N/A
Address
14th Floor, Number 100, Xintai 5th Road, Sec 1, Xizhi District, New Taipei City, Taipei, TWN
Genomics BioSci & Tech Co Ltd is a Taiwan based commercial genome sequencing company formed to develop medical genetic testing. The services of the company include Sanger sequence service, Synthesis Service and Genomic Service.

Genomics BioSci & Tech Co Headlines

No Headlines